Diabetic retinopathy is one of the most common complications of diabetes mellitus and the
leading cause of low vision and blindness worldwide. Mounting evidence demonstrates that …

Purpose Age-related eye diseases are becoming more prevalent. A notable increase has
been seen in the most common causes including glaucoma, age-related macular …

Purpose: In this study, we aim to investigate whether mesenchymal stem cell (MSC)-derived
exosomes (MSC-Exos) could regulate hyperglycemia-induced retinal inflammation by …

Clinical efficacy of intravitreal anti-VEGF drugs has been widely demonstrated in several
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …

Microvascular complications (retinopathy, nephropathy, and neuropathy) affect hundreds of
millions of patients with type 2 diabetes. They usually affect people with longstanding or …

Retinal vascular disease has the potential to affect hundreds of millions of people, with the
inherent risk of vision loss related to cystoid macular edema. Although there have been …

Currently, biological drug therapy for ocular angiogenesis treatment is based on the
administration of anti‐VEGF agents via intravitreal route. The molecules approved with this …

Topic Diabetic macular edema (DME) can be treated with either intravitreal anti-VEGF
injections or intravitreal corticosteroid injections. Clinical relevance: We provide an updated …

Background Central vision loss in diabetic retinopathy is commonly related to diabetic
macular edema (DME). The objective of this study was to describe changes between …

Mucosal healing is essential for treating ulcerative colitis (UC), which results from
imbalanced macrophage polarization and dysregulated inflammatory responses. However …